San Diego, California — October 2, 2025 — Leads & Copy — Cardiff Oncology, Inc. (Nasdaq: CRDF), a clinical-stage biotechnology company, announced its management will participate in two investor conferences in October 2025.
The Piper Sandler Virtual Oncology Symposium will feature a fireside chat with Mark Erlander, PhD (CEO), James Levine (CFO), and Roger Sidhu, MD (CMO) on October 9, 2025, at 1:00 PM ET. Contact Piper Sandler for attendance information.
Mark Erlander, CEO, will present a fireside chat at Noble Capital Markets’ Emerging Growth Virtual Equity Conference on October 9, 2025, at 2:00 PM ET. Interested parties can register at no cost. A webcast replay will be available within 48 hours on the Cardiff Oncology website.
Cardiff Oncology is developing novel therapies across a range of cancers by leveraging PLK1 inhibition. The lead asset, onvansertib, is being evaluated in combination with standard of care therapeutics in clinical programs.
James Levine, Chief Financial Officer, 858-952-7670, jlevine@cardiffoncology.com
Source: Cardiff Oncology, Inc.
